{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:54:54Z","timestamp":1793040894501,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Federal Ministry of Education and Research within the German Centre for Diabetes Research"},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["115798 (Innodia)"],"award-info":[{"award-number":["115798 (Innodia)"]}]},{"name":"German Diabetes Association"},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Robert Koch Institute, Germany"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0970-8","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T20:41:23Z","timestamp":1545424883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism"],"prefix":"10.1186","volume":"13","author":[{"given":"Alena","family":"Welters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Grulich-Henn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Fr\u00f6hlich-Reiterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Warncke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Mohnike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Blankenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolin","family":"Datz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Bollow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard W.","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,22]]},"reference":[{"issue":"2","key":"970_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4274\/jcrpe.1891","volume":"7","author":"K Rozenkova","year":"2015","unstructured":"Rozenkova K, Guemes M, Shah P, Hussain K. The diagnosis and Management of Hyperinsulinaemic Hypoglycaemia. J Clin Res Pediatr Endocrinol. 2015;7(2):86\u201397.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"1","key":"970_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/pedi.12453","volume":"18","author":"DD Leon De","year":"2017","unstructured":"De Leon DD, Stanley CA. Congenital hypoglycemia disorders: new aspects of etiology, diagnosis, treatment and outcomes: highlights of the proceedings of the congenital hypoglycemia disorders symposium, Philadelphia April 2016. Pediatr Diabetes. 2017;18(1):3\u20139.","journal-title":"Pediatr Diabetes"},{"key":"970_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fendo.2017.00156","volume":"8","author":"A Helleskov","year":"2017","unstructured":"Helleskov A, Melikyan M, Globa E, Shcherderkina I, Poertner F, Larsen AM, Filipsen K, Brusgaard K, Christiansen CD, Hansen LK, et al. Both Low Blood Glucose and Insufficient Treatment Confer Risk of Neurodevelopmental Impairment in Congenital Hyperinsulinism: A Multinational Cohort Study. Front Endocrinol (Lausanne). 2017;8:156.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3\u20134","key":"970_CR4","first-page":"301","volume":"26","author":"Y Levy-Shraga","year":"2013","unstructured":"Levy-Shraga Y, Pinhas-Hamiel O, Kraus-Houminer E, Landau H, Mazor-Aronovitch K, Modan-Moses D, Gillis D, Koren I, Dollberg D, Gabis LV. Cognitive and developmental outcome of conservatively treated children with congenital hyperinsulinism. J Pediatr Endocrinol Metab. 2013;26(3\u20134):301\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"970_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1053\/j.sempedsurg.2010.10.005","volume":"20","author":"A Ludwig","year":"2011","unstructured":"Ludwig A, Ziegenhorn K, Empting S, Meissner T, Marquard J, Holl R, Mohnike K. Glucose metabolism and neurological outcome in congenital hyperinsulinism. Semin Pediatr Surg. 2011;20(1):45\u20139.","journal-title":"Semin Pediatr Surg"},{"issue":"2","key":"970_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pedn.2004.12.009","volume":"20","author":"L Steinkrauss","year":"2005","unstructured":"Steinkrauss L, Lipman TH, Hendell CD, Gerdes M, Thornton PS, Stanley CA. Effects of hypoglycemia on developmental outcome in children with congenital hyperinsulinism. J Pediatr Nurs. 2005;20(2):109\u201318.","journal-title":"J Pediatr Nurs"},{"issue":"1","key":"970_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1530\/eje.0.1490043","volume":"149","author":"T Meissner","year":"2003","unstructured":"Meissner T, Wendel U, Burgard P, Schaetzle S, Mayatepek E. Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur J Endocrinol. 2003;149(1):43\u201351.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"970_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1542\/peds.107.3.476","volume":"107","author":"F Menni","year":"2001","unstructured":"Menni F, de Lonlay P, Sevin C, Touati G, Peigne C, Barbier V, Nihoul-Fekete C, Saudubray JM, Robert JJ. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics. 2001;107(3):476\u20139.","journal-title":"Pediatrics"},{"key":"970_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13023-015-0367-x","volume":"10","author":"A Welters","year":"2015","unstructured":"Welters A, Lerch C, Kummer S, Marquard J, Salgin B, Mayatepek E, Meissner T. Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers. Orphanet journal of rare diseases. 2015;10:150.","journal-title":"Orphanet journal of rare diseases"},{"key":"970_CR10","doi-asserted-by":"crossref","unstructured":"van der Steen I, van Albada ME, Mohnike K, Christesen HT, Empting S, Salomon-Estebanez M, Greve Rasmussen A, Verrijn Stuart A, van der Linde AAA, Banerjee I, et al. A Multicenter Experience with Long-Acting Somatostatin Analogues in Patients with Congenital Hyperinsulinism. Horm Res Paediatr. 2017.","DOI":"10.1159\/000485184"},{"issue":"1","key":"970_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13023-017-0653-x","volume":"12","author":"H Corda","year":"2017","unstructured":"Corda H, Kummer S, Welters A, Teig N, Klee D, Mayatepek E, Meissner T. Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism. Orphanet J Rare Dis. 2017;12(1):108.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"970_CR12","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1210\/jc.2014-1866","volume":"99","author":"H Demirbilek","year":"2014","unstructured":"Demirbilek H, Shah P, Arya VB, Hinchey L, Flanagan SE, Ellard S, Hussain K. Long-term follow-up of children with congenital hyperinsulinism on octreotide therapy. J Clin Endocrinol Metab. 2014;99(10):3660\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"970_CR13","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMoa1310967","volume":"370","author":"S Senniappan","year":"2014","unstructured":"Senniappan S, Alexandrescu S, Tatevian N, Shah P, Arya V, Flanagan S, Ellard S, Rampling D, Ashworth M, Brown RE, et al. Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia. N Engl J Med. 2014;370(12):1131\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"970_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13023-017-0621-5","volume":"12","author":"I Banerjee","year":"2017","unstructured":"Banerjee I, De Leon D, Dunne MJ. Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient. Orphanet J Rare Dis. 2017;12(1):70.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"970_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-016-0547-3","volume":"11","author":"M Salomon-Estebanez","year":"2016","unstructured":"Salomon-Estebanez M, Flanagan SE, Ellard S, Rigby L, Bowden L, Mohamed Z, Nicholson J, Skae M, Hall C, Craigie R, et al. Conservatively treated congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time. Orphanet J Rare Dis. 2016;11(1):163.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"970_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000284394","volume":"73","author":"A Kumaran","year":"2010","unstructured":"Kumaran A, Kapoor RR, Flanagan SE, Ellard S, Hussain K. Congenital hyperinsulinism due to a compound heterozygous ABCC8 mutation with spontaneous resolution at eight weeks. Horm Res Paediatr. 2010;73(4):287\u201392.","journal-title":"Horm Res Paediatr."},{"key":"970_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1750-1172-6-63","volume":"6","author":"JB Arnoux","year":"2011","unstructured":"Arnoux JB, Verkarre V, Saint-Martin C, Montravers F, Brassier A, Valayannopoulos V, Brunelle F, Fournet JC, Robert JJ, Aigrain Y, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis. 2011;6:63.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"970_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jpedsurg.2003.11.004","volume":"39","author":"CN Fekete","year":"2004","unstructured":"Fekete CN, de Lonlay P, Jaubert F, Rahier J, Brunelle F, Saudubray JM. The surgical management of congenital hyperinsulinemic hypoglycemia in infancy. J Pediatr Surg. 2004;39(3):267\u20139.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"970_CR19","doi-asserted-by":"publisher","first-page":"e98054","DOI":"10.1371\/journal.pone.0098054","volume":"9","author":"VB Arya","year":"2014","unstructured":"Arya VB, Senniappan S, Demirbilek H, Alam S, Flanagan SE, Ellard S, Hussain K. Pancreatic endocrine and exocrine function in children following near-total pancreatectomy for diffuse congenital hyperinsulinism. PLoS One. 2014;9(5):e98054.","journal-title":"PLoS One"},{"issue":"2","key":"970_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc11-1296","volume":"35","author":"J Beltrand","year":"2012","unstructured":"Beltrand J, Caquard M, Arnoux JB, Laborde K, Velho G, Verkarre V, Rahier J, Brunelle F, Nihoul-Fekete C, Saudubray JM, et al. Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care. 2012;35(2):198\u2013203.","journal-title":"Diabetes Care"},{"issue":"2","key":"970_CR21","first-page":"386","volume":"80","author":"G Leibowitz","year":"1995","unstructured":"Leibowitz G, Glaser B, Higazi AA, Salameh M, Cerasi E, Landau H. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab. 1995;80(2):386\u201392.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"970_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0022-3468(97)90207-4","volume":"32","author":"J Shilyansky","year":"1997","unstructured":"Shilyansky J, Fisher S, Cutz E, Perlman K, Filler RM. Is 95% pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycemia of the neonate? J Pediatr Surg. 1997;32(2):342\u20136.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"970_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/adc.79.5.435","volume":"79","author":"A Cade","year":"1998","unstructured":"Cade A, Walters M, Puntis JW, Arthur RJ, Stringer MD. Pancreatic exocrine and endocrine function after pancreatectomy for persistent hyperinsulinaemic hypoglycaemia of infancy. Arch Dis Child. 1998;79(5):435\u20139.","journal-title":"Arch Dis Child"},{"key":"970_CR24","doi-asserted-by":"crossref","unstructured":"Abraham MB, Jones TW, Naranjo D, Karges B, Oduwole A, Tauschmann M, Maahs DM. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2018:19 Suppl 27:178-192.","DOI":"10.1111\/pedi.12698"},{"issue":"2","key":"970_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000341525","volume":"78","author":"P Kuhnen","year":"2012","unstructured":"Kuhnen P, Marquard J, Ernert A, Meissner T, Raile K, Wannenmacher G, Blankenstein O. Long-term lanreotide treatment in six patients with congenital hyperinsulinism. Horm Res Paediatr. 2012;78(2):106\u201312.","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"970_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1530\/EJE-11-0874","volume":"166","author":"KH Quan Sang Le","year":"2012","unstructured":"Le Quan Sang KH, Arnoux JB, Mamoune A, Saint-Martin C, Bellanne-Chantelot C, Valayannopoulos V, Brassier A, Kayirangwa H, Barbier V, Broissand C, et al. Successful treatment of congenital hyperinsulinism with long-acting release octreotide. European journal of endocrinology \/ European Federation of Endocrine Societies. 2012;166(2):333\u20139.","journal-title":"European journal of endocrinology \/ European Federation of Endocrine Societies."},{"issue":"8","key":"970_CR27","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1210\/jc.2011-0605","volume":"96","author":"D Modan-Moses","year":"2011","unstructured":"Modan-Moses D, Koren I, Mazor-Aronovitch K, Pinhas-Hamiel O, Landau H. Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel). J Clin Endocrinol Metab. 2011;96(8):2312\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"970_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.4274\/jcrpe.2773","volume":"8","author":"S Unal","year":"2016","unstructured":"Unal S, Gonulal D, Ucakturk A, Siyah Bilgin B, Flanagan SE, Gurbuz F, Tayfun M, Elmaogullari S, Arasli A, Demirel F, et al. A novel homozygous mutation in the KCNJ11 gene of a neonate with congenital Hyperinsulinism and successful management with Sirolimus. J Clin Res Pediatr Endocrinol. 2016;8(4):478\u201381.","journal-title":"J Clin Res Pediatr Endocrinol."},{"issue":"5","key":"970_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000443398","volume":"85","author":"M Guemes","year":"2016","unstructured":"Guemes M, Shah P, Rozenkova K, Gilbert C, Morgan K, Hussain K. Severe Hyperinsulinaemic Hypoglycaemia in Beckwith-Wiedemann syndrome due to paternal uniparental Disomy of 11p15.5 managed with Sirolimus therapy. Horm Res Paediatr. 2016;85(5):353\u20137.","journal-title":"Horm Res Paediatr."},{"issue":"5","key":"970_CR30","doi-asserted-by":"publisher","first-page":"e1369","DOI":"10.1542\/peds.2014-4200","volume":"136","author":"U Meder","year":"2015","unstructured":"Meder U, Bokodi G, Balogh L, Korner A, Szabo M, Pruhova S, Szabo AJ. Severe Hyperinsulinemic hypoglycemia in a neonate: response to Sirolimus therapy. Pediatrics. 2015;136(5):e1369\u201372.","journal-title":"Pediatrics"},{"issue":"11\u201312","key":"970_CR31","first-page":"1391","volume":"28","author":"MB Abraham","year":"2015","unstructured":"Abraham MB, Shetty VB, Price G, Smith N, Bock M, Siafarikas A, Resnick S, Whan E, Ellard S, Flanagan SE, et al. Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemia. J Pediatr Endocrinol Metab. 2015;28(11\u201312):1391\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5\u20136","key":"970_CR32","first-page":"695","volume":"28","author":"P Shah","year":"2015","unstructured":"Shah P, Arya VB, Flanagan SE, Morgan K, Ellard S, Senniappan S, Hussain K. Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation. J Pediatr Endocrinol Metab. 2015;28(5\u20136):695\u20139.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"970_CR33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1515\/jpem-2016-0229","volume":"30","author":"R Al-Balwi","year":"2017","unstructured":"Al-Balwi R, Al-Atawi M, Al-Otaibi A, Babiker O, Al-Mutair A. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism. J Pediatr Endocrinol Metab. 2017;30(9):1013\u20137.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"12","key":"970_CR34","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1210\/jc.2016-2711","volume":"101","author":"M Szymanowski","year":"2016","unstructured":"Szymanowski M, Estebanez MS, Padidela R, Han B, Mosinska K, Stevens A, Damaj L, Pihan-Le Bars F, Lascouts E, Reynaud R, et al. mTOR inhibitors for the treatment of severe congenital Hyperinsulinism: perspectives on limited therapeutic success. J Clin Endocrinol Metab. 2016;101(12):4719\u201329.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"970_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/0971-9261.98119","volume":"17","author":"P Goel","year":"2012","unstructured":"Goel P, Choudhury SR. Persistent hyperinsulinemic hypoglycemia of infancy: an overview of current concepts. J Indian Assoc Pediatr Surg. 2012;17(3):99\u2013103.","journal-title":"J Indian Assoc Pediatr Surg"},{"issue":"11","key":"970_CR36","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2015-2539","volume":"100","author":"K Lord","year":"2015","unstructured":"Lord K, Radcliffe J, Gallagher PR, Adzick NS, Stanley CA, De Leon DD. High risk of diabetes and neurobehavioral deficits in individuals with surgically treated Hyperinsulinism. J Clin Endocrinol Metab. 2015;100(11):4133\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"970_CR37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000323532","volume":"75","author":"W Barthlen","year":"2011","unstructured":"Barthlen W, Mohnike W, Mohnike K. Techniques in pediatric surgery: congenital hyperinsulinism. Horm Res Paediatr. 2011;75(4):304\u201310.","journal-title":"Horm Res Paediatr."},{"key":"970_CR38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2147\/DMSO.S99701","volume":"9","author":"J Makuc","year":"2016","unstructured":"Makuc J. Management of pancreatogenic diabetes: challenges and solutions. Diabetes Metab Syndr Obes. 2016;9:311\u20135.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"970_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF00253865","volume":"22","author":"A Tiengo","year":"1982","unstructured":"Tiengo A, Bessioud M, Valverde I, Tabbi-Anneni A, Delprato S, Alexandre J, Assan R. Absence of islet alpha cell function in pancreatectomized patients. Diabetologia. 1982;22(1):25\u201332.","journal-title":"Diabetologia"},{"issue":"4 Pt 1","key":"970_CR40","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2337\/diab.31.4.346","volume":"31","author":"R Nosadini","year":"1982","unstructured":"Nosadini R, del Prato S, Tiengo A, Duner E, Toffolo G, Cobelli C, Faronato PP, Moghetti P, Muggeo M. Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes. 1982;31(4 Pt 1):346\u201355.","journal-title":"Diabetes"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0970-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T19:19:14Z","timestamp":1576955954000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0970-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["970"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0970-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"20 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The DPV initiative and the analysis of anonymized data related to quality of care were approved by the ethics committee of the University of Ulm. The institutional review boards at each participating centre confirmed protection of patient primary rights.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"230"}}